US Broker Ratings

Absci Corporation (ABSI) Stock Analysis: A Biotech Player with 241% Potential Upside

For investors eyeing the biotechnology sector, Absci Corporation (NASDAQ: ABSI) presents a fascinating opportunity. Specializing in AI-driven drug discovery, Absci operates at the intersection of cutting-edge technology and healthcare innovation...

Evolent Health, Inc (EVH) Stock Analysis: Exploring a 59.89% Potential Upside in Health Information Services

Evolent Health, Inc (NYSE: EVH) is making waves in the healthcare industry, specifically within the Health Information Services sector. With a market capitalization of $1.12 billion, this Arlington, Virginia-based company..

Integra LifeSciences Holdings C (IART): Analyzing the Healthcare Device Leader with a 1.24% Upside Potential

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a stalwart in the healthcare sector, specializes in medical devices that cater to a range of surgical and wound care applications. This Princeton, New..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Strong Buy Ratings Amid Biotech Growth

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is making waves in the biotechnology sector with its promising developments in the treatment of autoimmune diseases. Headquartered in Edmonton, Canada, the company is carving..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 46% Potential Upside in the Medical Innovation Sector

Pulse Biosciences, Inc. (NASDAQ: PLSE), a cutting-edge player in the healthcare sector, is capturing investor interest with a potential upside of 46.28%, as reflected in its current analyst ratings. Specializing..

The Pennant Group, Inc. (PNTG) Stock Analysis: Exploring a Potential 37% Upside in Healthcare

For investors seeking exposure in the healthcare sector, The Pennant Group, Inc. (NASDAQ: PNTG) presents an intriguing opportunity. With a market capitalization of $847.11 million, Pennant operates in the medical..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Assessing the 8.45% Upside Potential Amidst Volatile Metrics

Pacira BioSciences, Inc. (NASDAQ: PCRX) operates at the forefront of non-opioid pain management solutions within the healthcare sector. With its innovative product lineup and strategic industry positioning, this specialty drug..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 14.84% Potential Upside Amidst a Challenging Landscape

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specializing in diagnostics and research, offers a unique investment opportunity despite facing some headwinds. With a market capitalization of..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a Potential 25.98% Upside

For investors seeking opportunities within the healthcare sector, U.S. Physical Therapy, Inc. (NYSE: USPH) presents a compelling case. As a key player in the medical care facilities industry, USPH specializes..

Novavax, Inc. (NVAX) Stock Analysis: Investors Eye 61.71% Potential Upside Amid Volatile Market Conditions

Novavax, Inc. (NASDAQ: NVAX), a healthcare sector heavyweight specializing in biotechnology, is captivating investor attention with its substantial potential upside of 61.71%. This American company has carved a niche in..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: 44.97% Potential Upside Captures Investor Attention

Investors with an eye on the healthcare sector may find Establishment Labs Holdings Inc (NASDAQ: ESTA) an intriguing option, especially given its impressive potential upside of 44.97%. As a prominent..

Harrow, Inc. (HROW) Stock Analysis: Analyst Ratings Signal a Promising 51.12% Upside for Investors

Harrow, Inc. (HROW), a pivotal player in the healthcare sector, is gaining significant attention from investors due to its strong potential for growth. The company, headquartered in Nashville, Tennessee, specializes..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Navigating a 30% Potential Upside in HealthTech

GoodRx Holdings, Inc. (NASDAQ: GDRX) presents a compelling opportunity for investors seeking exposure in the health information services sector, known for its innovative approach to healthcare costs in the United..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Exploring a Promising 153% Upside Potential

Vera Therapeutics, Inc. (NASDAQ: VERA), a clinical-stage biotechnology company, is catching the eye of investors with its ambitious approach to tackling serious immunological diseases. With a market capitalization of $1.58..

agilon health, inc. (AGL) Stock Analysis: Exploring the 23% Potential Upside

agilon health, inc. (NYSE: AGL) presents an intriguing proposition for investors focused on the healthcare sector, particularly given its role in transforming senior care. The company operates at the intersection..

Bausch Health Companies Inc. (BHC) Stock Analysis: Unpacking the Healthcare Giant’s Growth Potential and Market Position

Bausch Health Companies Inc. (NYSE: BHC), a prominent name in the healthcare sector, continues to be a focal point for investors keen on specialty and generic drug manufacturing. Headquartered in..

Investor Outlook: Travere Therapeutics, Inc. (TVTX) and Its 65% Potential Upside

Travere Therapeutics, Inc. (NASDAQ: TVTX) is garnering significant attention among investors, primarily due to its considerable potential upside. With a target price range that suggests a 65.09% increase from its..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: A Healthcare Investment with Modest Upside

Pediatrix Medical Group, Inc. (NYSE: MD), a prominent player in the healthcare sector, specifically within medical care facilities, is drawing attention from investors due to its modest market cap of..

Immunocore Holdings plc (IMCR) Stock Analysis: Exploring a Potential 69.75% Upside in the Biotech Sector

Immunocore Holdings plc (NASDAQ: IMCR), a prominent player in the biotechnology sector, has been capturing investor attention with its innovative approach to immunotherapy. Headquartered in Abingdon, United Kingdom, the company..

Dynavax Technologies Corporation (DVAX): Investor Outlook Reveals a Compelling 135% Upside Potential

Dynavax Technologies Corporation (NASDAQ: DVAX) stands out in the healthcare sector, not just for its innovative vaccine technologies but also for its intriguing investment potential. With a market capitalization of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds